NASDAQ
Evaxion Biotech A/S (EVAX) has a current ratio of 5.85x as of Monday, May 25, 2026. This represents a 48.76% increase compared to its 12-month average of 3.93x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.